Luo M - Search Results

1

Distinct prognostic values of ALDH1 isoenzymes in breast cancer.

Wu S, Xue W, Huang X, Yu X, Luo M, Huang Y, Liu Y, Bi Z, Qiu X, Bai S. Wu S, et al. Among authors: luo m. Tumour Biol. 2015 Apr;36(4):2421-6. doi: 10.1007/s13277-014-2852-6. Epub 2015 Jan 13. Tumour Biol. 2015. PMID: 25582316

2

Phase I clinical trial of nasopharyngeal radiotherapy and concurrent celecoxib for patients with locoregionally advanced nasopharyngeal carcinoma.

Xue WP, Bai SM, Luo M, Bi ZF, Liu YM, Wu SK. Xue WP, et al. Among authors: luo m. Oral Oncol. 2011 Aug;47(8):753-7. doi: 10.1016/j.oraloncology.2011.06.002. Epub 2011 Jun 25. Oral Oncol. 2011. PMID: 21708478 Clinical Trial.

3

Ubc9 expression predicts chemoresistance in breast cancer.

Chen SF, Gong C, Luo M, Yao HR, Zeng YJ, Su FX. Chen SF, et al. Among authors: luo m. Chin J Cancer. 2011 Sep;30(9):638-44. doi: 10.5732/cjc.011.10084. Chin J Cancer. 2011. PMID: 21880185 Free PMC article.

4

The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.

Bai S, Chen T, Yu X, Luo M, Chen X, Lin C, Lai Y, Huang H. Bai S, et al. Among authors: luo m. Oncol Rep. 2017 May;37(5):2819-2828. doi: 10.3892/or.2017.5510. Epub 2017 Mar 16. Oncol Rep. 2017. PMID: 28440481

5

[Corrigendum] The specific killing effect of matrine on castration‑resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.

Bai S, Chen T, Yu X, Luo M, Chen X, Lin C, Lai Y, Huang H. Bai S, et al. Among authors: luo m. Oncol Rep. 2020 Dec;44(6):2793-2794. doi: 10.3892/or.2020.7784. Epub 2020 Sep 29. Oncol Rep. 2020. PMID: 33125118

6

Role of brachytherapy in post-operative cervical cancer patients with risk factors other than positive stump.

Yu XL, Hu J, Cai XL, Fang JN, Yang J, Luo M, Bai SM. Yu XL, et al. Among authors: luo m. Brachytherapy. 2023 Mar-Apr;22(2):166-173. doi: 10.1016/j.brachy.2022.10.002. Epub 2022 Nov 12. Brachytherapy. 2023. PMID: 36376227 Free article.

7

miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.

Luo M, Ding L, Li Q, Yao H. Luo M, et al. Breast Cancer. 2017 Sep;24(5):673-682. doi: 10.1007/s12282-017-0756-1. Epub 2017 Jan 30. Breast Cancer. 2017. PMID: 28138801

8

Combined treatment of fasudil and glutamate decreased the viability of human glioblastoma cells by excitotoxicity through NMDAR in vitro.

He M, Luo M, Chen S, Li K, Zheng M, Weng Y, Pi R, Liu A. He M, et al. Among authors: luo m. Int J Clin Exp Med. 2015 Oct 15;8(10):18434-40. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26770449 Free PMC article.

9

IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.

Li K, Ouyang L, He M, Luo M, Cai W, Tu Y, Pi R, Liu A. Li K, et al. Among authors: luo m. Oncotarget. 2017 Apr 25;8(17):28865-28879. doi: 10.18632/oncotarget.15868. Oncotarget. 2017. PMID: 28427200 Free PMC article.

10

Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.

He M, Luo M, Liu Q, Chen J, Li K, Zheng M, Weng Y, Ouyang L, Liu A. He M, et al. Among authors: luo m. J Neurooncol. 2016 Apr;127(2):261-70. doi: 10.1007/s11060-015-2044-2. Epub 2016 Jan 2. J Neurooncol. 2016. PMID: 26725099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,995 results

Search Page

Filters